INmune Bio Inc (NASDAQ: INMB) is -19.22% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $10.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INMB stock was last observed hovering at around $6.38 in the last trading session, with the day’s gains setting it 379.33%.
Currently trading at $385.71K, the stock is -15.99% and -16.98% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.1 million and changing 2098235% at the moment leaves the stock -7.36% off its SMA200. INMB registered 33.19% gain for a year compared to 6-month gain of 24.90%.
The stock witnessed a -16.62% loss in the last 1 month and extending the period to 3 months gives it a -23.40%, and is -19.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.52% over the week and 5.45% over the month.
INmune Bio Inc (INMB) has around 22 employees, a market worth around $144.37M and $0.05M in sales. Profit margin for the company is -81592.00%. Distance from 52-week low is 43.98% and -40.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-136.56%).
The EPS is expected to grow by 20.36% this year.
INmune Bio Inc (INMB) Top Institutional Holders
The shares outstanding are 22.93M, and float is at 16.50M with Short Float at 37.45%.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.81 million shares valued at $7.17 million. The investor’s holdings represent 4.2103% of the INMB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.63 million shares valued at $5.54 million to account for 3.2542 of the shares outstanding. The other top investors are CVI HOLDINGS, LLC which holds 0.6 million shares representing 3.0888% and valued at over $5.26 million, while PRAETORIAN PR LLC holds 2.512 of the shares totaling 0.48 million with a market value of $4.28 million.
INmune Bio Inc (INMB) Insider Activity
The most recent transaction is an insider purchase by Moss David J,the company’sChief Financial Officer. SEC filings show that Moss David J bought 10,000 shares of the company’s common stock on Sep 30 ’24 at a price of $5.29 per share for a total of $52868.0. Following the purchase, the insider now owns 1.29 million shares.
INmune Bio Inc disclosed in a document filed with the SEC on Sep 12 ’24 that Tesi Raymond Joseph (President and CEO) bought a total of 15,380 shares of the company’s common stock. The trade occurred on Sep 12 ’24 and was made at $6.38 per share for $98048.0. Following the transaction, the insider now directly holds 1.55 million shares of the INMB stock.
Still, SEC filings show that on Sep 12 ’24, Moss David J (Chief Financial Officer) acquired 7,690 shares at an average price of $6.38 for $49024.0. The insider now directly holds 1,275,869 shares of INmune Bio Inc (INMB).
